Advertisement

Topics

Companies Related to "IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma" [Most Relevant Company Matches] - Page: 5 RSS

23:59 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma" found in our extensive corporate database of over 50,000 company records.

Showing "PE38KDEL Immunotoxin Treating Patients With Recurrent Malignant Astrocytoma" Companies 101–125 of 4,000+

Probably Relevant

Arrhythmia Research Technology

Arrhythmia Research Technology, Inc. (ART) was founded in 1981 specifically to capitalize on the marketing of certain patents or licenses concerning the application of signal-averaged electrocardiography (SAECG) for the detection of cardiac late potentials. Late potentials have been shown to be an indicator of risk for ventricular tachycardia (VT) which can degenerate into ventricular fibrillati...


Boston Scientific

Boston Scientific Corporation (NYSE: BSX) is the world's largest medical device company dedicated to less-invasive therapies. The Company's products and technologies are designed to reduce risk, trauma, cost, procedure time and the need for aftercare.These products and technologies are generally used for enlarging narrowed blood vessels to prevent heart attack and stroke, clearing passages blocked...

Zyga Technology, Inc.

Based in Minneapolis, MN, Zyga Technology, Inc. was founded to develop and market innovative, minimally invasive surgical solutions to treat conditions of the spine. In addition to SImmetry the company is also developing the Glyder(TM) Facet Resurfacing System. Glyder is being developed as a minimally invasive technique for treating patients with facetogenic pain. Zyga has put together a team of ...


Nodality, Inc.

Nodality develops and commercializes the next generation of personal diagnostic tests by characterizing cell signaling pathways in defined cellular sub-populations of malignant and normal cells. The South San Francisco based company applies proprietary multiparametric Single Cell Network Profiling (SCNP) technology to develop highly predictive biological ...

Arbios Systems, Inc.

Arbios Systems, Inc. is developing proprietary medical devices and cell-based therapies to enhance the survival of millions of patients each year who experience, or are at risk for, life-threatening episodes of liver failure. The Arbios product candidate portfolio includes the SEPET™ Liver Assist Device, a novel blood purification therapy that provides enhanced “liver dialysis,” and the H...

Spinal Kinetics, Inc.

Founded in 2003, Spinal Kinetics is a privately held medical device company focused on partnering with spine surgeons to develop innovative and practical motion preservation systems for treating degenerative diseases of the spine. The M6-C cervical and M6-L lumbar artificial discs have rapidly established themselves among the leading artificial discs avail...

MabVax Therapeutics, Inc.

MabVax Therapeutics, Inc. is a clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer. The company was formed to exploit key aspects of the work of Dr. Philip Livingston and colleagues at MSKCC who have developed cancer vaccines against gangliosides and other carbohydrate antigens that...

Ocular Surface Center, P.A.

Ocular Surface Foundation (OSF) is a non-profit public medical research foundation (501c3) established in 1999, and carries s single mission of promoting the spread of the knowledge and skills that are important for treating ocular surface diseases. Under the leadership of the President, Billy K. Yeh, M.D., Ph.D., OSF supports research and educational programs that may create a differentiable valu...

Clearside Biomedical, Inc.

Clearside Biomedical is an Atlanta-based, clinical phase ophthalmic pharmaceutical company improving drug performance through tissue-targeted microinjection into distinct compartments of the eye to treat sight-threatening disease. Clearside Biomedical’s proprietary microinjection dosing platform consistently delivers drug to the suprachoroidal space (...

CorMedix Inc.

CorMedix Inc. is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac and renal dysfunction, also known as cardiorenal disease. CorMedix’s goal is to treat kidney disease by reducing the commonly associated cardiovascular and metabolic complications, in effect, tr...

Speedel

Speedel is a biopharmaceutical company that seeks to create value for patients, partners and investors by developing innovative therapies for cardiovascular and metabolic diseases. Speedel is a world leader in renin inhibition, a promising new approach with significant potential for treating cardiovascular diseases. Our lead product candidate SPP100 (Aliskiren), the first-in-class renin inhibitor,...

Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world’s largest philanthropic source of support for accelerating the world’s most promising research for discovering better treatments and cures for prostate cancer. Founded in 1993, the PCF has raised nearly $400 million and provided funding to more than 1,500 researchers at nearly 200 institutions wor...

Laurimed, LLC

Laurimed, LLC, based in Redwood City, Calif., is a privately owned medical device company focused on new, cost-effective medical technologies that improve patient outcomes, safety, and physician ease-of-use. The company’s PolypVac device is a breakthrough technology for ENT specialists treating patients with nasal polyps – quickly, easily and vir...

Laurimed LLC

Laurimed, LLC, based in Redwood City, Calif., is a privately owned medical device company focused on new, cost-effective medical technologies that improve patient outcomes, safety, and physician ease-of-use. The company’s PolypVac device is a breakthrough technology for ENT specialists treating patients with nasal polyps – quickly, easily and vir...

Ignyta Inc.

At Ignyta, we fight cancer – a formidable opponent that manifests as thousands of different molecularly defined diseases and takes away millions of lives globally, every year. In this fight, our big hairy audacious goal (BHAG) is not just to shrink tumors but to eradicate residual disease – the source of cancer relapse and recurrence – in pr...

Cappella, Inc.

Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD), specifically bifurcation disease. Cappella’s initial product, the Sideguard® Coronary Sidebranch Stent & Delivery System offers interventional cardiologists a straightforward, effective solution that focuses on treating...

Cappella Inc.

Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease. Cappella's initial product, the Sideguard® Coronary Sidebranch Stent & Delivery System offers interventional cardiologists a straightforward, effective solution that focuses on treating the sidebranch of diseased coronary ...

NeuroVasx, Inc.

To develop and commercialize unique technologies and methodologies for the improved treatment and long term care of stroke patients.NeuroVasx, Inc. was founded in 1997 to produce unique diagnostic and therapeutic devices for the neurovascular embolization market. Utilizing unique materials, NeuroVasx's products are intended for the treatment of intracranial aneurysms that, because of their morphol...

Lpath

Lpath, Inc., headquartered in San Diego, California, is a theranostics company focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases. Lpath's lead product candidate, Sphingomab™, is a monoclonal antibody (mAb) against a validated cancer target, sphingosine-1-phosphate (S1P), and has demonstrated compelling results against six different forms of sol...

Premiere Oncology

Premiere Oncology is a center of excellence dedicated to treating cancer by providing comprehensive and holistic clinical care with attention to issues of survivorship and longevity. The group conducts meaningful oncology research with responsibility and integrity. The aim of the research program is to offer the hopes and benefits of cutting edge treatment to patients while generating data of th...

Kun Run Biotechnology, Inc.

Kun Run Biotechnology, Inc., together with its subsidiaries, engages in the manufacture and sale of polypeptide medicines and small molecule drugs. It uses solid phase peptide synthesis (SPPS) and advanced purifying technology to produce various therapeutic polypeptide drugs, of which "TP-5" is the most known for efficiently regulating humans' immune systems in order to defend and cure maligna...

Hygieia, Inc.

Hygieia, Inc. is an emerging diabetes health care company developing new ways to improve the effectiveness of therapy while reducing the cost of diabetes care. Hygieia’s first product is a handheld Diabetes Insulin Guidance System (DIGS™) designed to improve insulin therapy effectiveness for patients. DIGS works in a way that makes it a feasible ...

Intact Vascular

Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack-It Endovascular Stapler™ is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease. This technology will offer physicians a new treatment option for treating peripheral ar...

Intact Vascular, Inc.

Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack-It Endovascular Stapler™ is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease. This technology will offer physicians a new treatment paradigm for treating peripheral ...

Sacred Heart Hospital

Sacred Heart Hospital strives to provide patients the best, most specialized treatment available by blending advanced technology with the Franciscan tradition to improve health by treating the whole person - body, mind and spirit. The exploration of the benefits of robotics in therapy is important to Sacred Heart Hospital as they strive to bring the newest, most innovative technologies to the regi...


More From BioPortfolio on "IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks